why choose us

First received: August 4, 2022

Clinical Trial: A Bioequivalence Study of APX001 High-load and Low-load Tablets

Study Status: Completed

Recruit Status: Completed

Condition: Invasive Fungal Infections

Study Type: Interventional


Official Title: A 3-TREATMENT, 3-PERIOD, 6-SEQUENCE RANDOMIZED CROSSOVER SINGLE-DOSE STUDY EVALUATING THE BIOEQUIVALENCE OF HIGH-LOAD AND LOW-LOAD ORAL TABLET FORMULATIONS OF APX001 AND THE EFFECT OF FOOD ON THE ABSO

Brief Summary: A study to learn about the bioequivalence (the biochemical similarity of two medicines that share the same active ingredient and desired outcome for patients) of the study medicine called APX001 in healthy participants.

Read more